Institutional Investors Adjust Holdings in Bristol Myers Squibb Amid Dividend Hike

Bristol Myers Squibb (BMY) is witnessing a shift in its institutional investor base following its latest quarterly performance. Caisse Des Depots ET Consignations reduced its stake in the pharmaceutical giant by 36.7% during the third quarter, selling over 21,000 shares. Conversely, Norges Bank initiated a substantial new position, helping push total institutional ownership to 76.41%. Despite reporting mixed third-quarter earnings that missed earnings per share (EPS) estimates, the company exceeded revenue expectations. In a move to bolster investor confidence, Bristol Myers Squibb raised its quarterly dividend and issued profitability guidance for fiscal year 2026. Market analysts view these ownership changes as standard portfolio rebalancing rather than a shift in long-term sentiment toward the stock.